PCM
AYTU icon

Perritt Capital Management’s AYTU BioPharma AYTU Stock Holding History

Perritt Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$52K Buy
+20,000
New +$44.9K 0.09% 79

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Perritt Capital Management's AYTU Position: Q4 2025 in Review

Perritt Capital Management opened a new position in AYTU BioPharma (AYTU) in Q4 2025: 20,000 shares worth $52K. The stake represents 0.09% of the portfolio and ranks #79 among its holdings.

39 funds tracked by Wall St. Rank hold AYTU as of Q4 2025.

  • Perritt Capital Management held 20,000 shares of AYTU BioPharma worth $52K as of Q4 2025.
  • AYTU BioPharma was a new Perritt Capital Management position in Q4 2025.
  • AYTU BioPharma made up 0.09% of Perritt Capital Management's portfolio in Q4 2025, its #79 holding.
  • 39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.